Catalyst Wire Dossier Catalyst Wire Dossier

VABOMERE

MEROPENEM-VABORBACTAM · Melinta Therapeutics, LLC
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for VABOMERE, covering 2017-08-29 to 2026-02-20. Get the full timeline:

Most recent: FDA Approved: VABOMERE — Supplemental Application (Melinta Therapeutics, LLC)

See pricing